Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases

计划入组 26 人 · 首次发布于 2016 年 9 月 23 日

Sitravatinib and Tislelizumab in Patients With Metastatic Uveal Melanoma With Liver Metastases.

计划入组 16 人 · 首次发布于 2022 年 9 月 15 日

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

计划入组 28 人 · 首次发布于 2021 年 1 月 28 日

aptamer-drug conjugate (uveal melanoma)

C-1A

Melphalan(Alkeran, Evomela, Phelinun, Pepaxti)

C₁₃H₁₈Cl₂N₂O₂ · Rx

MELANOMA INSTITUTE AUSTRALIA

Australia

MELANOMA AND SKIN CANCER TRIALS LIMITED

Australia

The Trustee for Weigh Less With Jess Trust

Australia

UVA Health Becomes First in Virginia to Offer Hepzato for Uveal Melanoma with Liver Metastases

Social Security Adds 14 Conditions to Compassionate Allowances List, Expanding Fast-Track Disability Benefits

Novel Treatment Landscape Expands for Uveal Melanoma with Multiple Promising Therapies in Development